PARP1 and cancer: Our data confirm that PARP inhibition‐induced DNA damage can trigger G2/M checkpoint activation in HR‐deficient cancer cells (Jelinic and Levine, 2014; Maya‐Mendoza et al., 2018; Prasad et al., 2017; Ray Chaudhuri et al., 2016; Rein et al., 2015).